CEBPD

CCAAT Enhancer Binding Protein Delta

Gene Information Card

Symbol CEBPD
Full Name CCAAT Enhancer Binding Protein Delta
Gene Type Protein coding
Chromosomal Location 8q11.21
NCBI Gene ID 1052 ncbi.nlm.nih.gov/gene/1052
Ensembl ID ENSG00000121879
UniProt ID P49716
OMIM ID 116898
HGNC ID 1834
Aliases CELF, CRP3, NF-IL6-beta

Description

CEBPD (CCAAT Enhancer Binding Protein Delta) is a transcription factor belonging to the basic leucine zipper (bZIP) family. It regulates genes involved in immune and inflammatory responses, cell differentiation, metabolism, and apoptosis. CEBPD is expressed in various tissues and plays critical roles in adipogenesis, mammary gland development, and acute phase response. Dysregulation of CEBPD is implicated in several cancers and inflammatory diseases.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Breast Cancer CEBPD overexpression promotes tumor growth and metastasis through regulation of cell cycle and apoptosis genes. PMID: 25636800; COSMIC
Acute Myeloid Leukemia CEBPD mutations or altered expression contribute to impaired myeloid differentiation. PMID: 21572415; ClinVar
Inflammatory Bowel Disease CEBPD regulates pro-inflammatory cytokine expression in intestinal epithelial cells. PMID: 23431263
Obesity and Metabolic Syndrome CEBPD is involved in adipocyte differentiation and lipid metabolism. PMID: 19033668

Expression Profile

Tissue Expression
Tissue nTPM level
Adipose tissue 12.5 Medium
Liver 8.3 Medium
Mammary gland 15.1 High
Lung 6.2 Low
Bone marrow 4.8 Low
Cell Line Expression
Cell Line nTPM Notes
MCF-7 (breast cancer) 18.4 High expression
HepG2 (liver cancer) 9.7 Moderate expression
THP-1 (monocyte) 14.2 High expression upon LPS stimulation
K562 (leukemia) 3.1 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.637C>T (p.Arg213Trp) Missense <0.1% Altered DNA binding affinity; reported in AML
c.832_833insA (p.Thr278Asnfs*12) Frameshift <0.1% Loss of function; associated with myeloid disorders
c.1A>G (p.Met1Val) Start loss <0.1% Loss of protein expression; reported in COSMIC
Mutation functional classification

Loss of Function (LOF)

Frameshift and start loss mutations lead to truncated or absent protein, impairing transcriptional activation of target genes.

Gain of Function (GOF)

Missense mutations in the bZIP domain may enhance DNA binding or cofactor recruitment, promoting oncogenic signaling.

Dominant Negative (DN)

Some CEBPD mutants can dimerize with wild-type C/EBP proteins and inhibit their function, disrupting normal differentiation.

Pathways

IL-6 signaling pathway (Reactome: R-HSA-1059683)
Adipogenesis (WikiPathways: WP236)
TNF-alpha signaling (KEGG: hsa04668)
Acute phase response (KEGG: hsa04610)

Protein Summary

CEBPD is a 269-amino acid transcription factor with a C-terminal bZIP domain mediating dimerization and DNA binding. It recognizes CCAAT motifs in promoter regions. The protein is induced by inflammatory stimuli (e.g., IL-6, LPS) and regulates target genes involved in cell cycle control, differentiation, and immune response. Post-translational modifications include phosphorylation and sumoylation, modulating its activity and stability.

Related Products

Product name Cat.No. Species Gene ID
CEBPD Knockout HEK293 Cell Line EDJ-KQ3212 Human 1052 Details Get a Quote
CEBPD Knockout A-549 Cell Line EDJ-KQ24685 Human 1052 Details Get a Quote
CEBPD Knockout HCT 116 Cell Line EDJ-KQ24686 Human 1052 Details Get a Quote
CEBPD Knockout HeLa Cell Line EDJ-KQ24687 Human 1052 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: